CEO of healthcare start-up describes challenging times for venture funding
What’s the future like for healthcare companies when it comes to venture investment? Eric Stone, Co-Founder and Chief Executive Officer of Velano Vascular, writes the following in a publication named STAT: “New deals are exceedingly rare right now, and industry pundits say that the deals that do get done are on far less frothy, or certainly more realistic, terms — approximately 30 percent lower valuations and falling — than before COVID-19.” He continues: “The word on the street is that venture capital firms are looking for a two-year runway, a difficult measure to assess in times of extreme uncertainty.” Click here for the full article.
